Join KBI Biopharma at Outsourced Pharma Large Molecule Drug Substance and Development Open Capacity Update in May 2024. We look forward to seeing you online!
About KBI Biopharma:
KBI Biopharma is a leading global contract development and manufacturing organization (CDMO) providing fully integrated, accelerated drug development and biologics manufacturing services and expertise to life science companies. With each of our 500+ client partners, we work closely to personalize and accelerate drug development programs. Built upon a foundation of world-class analytics capabilities and extensive scientific and technical expertise, we deliver robust process development and clinical and commercial cGMP manufacturing services for mammalian, microbial, and cell therapy programs. Recognized for quality manufacturing, we help clients advance drug candidates into the clinic and beyond.
Learn more about KBI Biopharma >>
Leading CDMOs share their current available capacity - and associated capabilities, facility locations, and timelines - to help you identify options for your development and manufacturing needs.
Dive into the biopharmaceutical realm, where the synthesis of biologically derived APIs encompasses cell line development, fermentation, and sophisticated purification techniques. The event will feature insights into process optimization and scale-up, which are crucial for meeting production demands without compromising quality. Discover the meticulous quality control practices that underpin the production of biopharmaceuticals, laying the groundwork for novel biologic therapies.